The Ropivacaine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Ropivacaine size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Ropivacaine market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Ropivacaine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Lumbar Epidural Administration
Thoracic Epidural Administration
Regional Block
Market segment by Application can be divided into
Anesthesia
Systemic Neuropathic Pain
Postherpes Pain
Post-Operative Pain
Surgical Analgesia
Labor Analgesia
Other
The key market players for global Ropivacaine market are listed below:
AstraZeneca
Aspen Pharmacare
Celgene
Taiwan Liposome Company
Nuvo Pharmaceuticals
Heron Therapeutics
Encore Therapeutics
PainReform Ltd
Anhui Wellman Pharmaceutical
Yichang Renfu Pharmaceutical
Shandong New Era Pharmaceutical
Shanxi Pude Pharmaceutical
Guangdong Huarun Shunfeng Pharmaceutical
Guangdong Jiabo Pharmaceutical
Chengdu Tiantaishan Pharmaceutical
Yangtze Pharmaceutical Group
Jiangsu Hengrui Pharmaceutical
Jiangsu Enhua Pharmaceutical
Hebei Yipin Pharmaceutical
Zhejiang Xianju Pharmaceutical
Hainan Sida Pharmaceutical
Xi'an Hanfeng Pharmaceutical
Chenxin Pharmaceutical
Shaanxi Bosen Biopharmaceutical
Qilu Pharmaceutical
Shenyang Sansheng Pharmaceutical
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Ropivacaine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Ropivacaine, with price, sales, revenue and global market share of Ropivacaine in 2018 and 2019.
Chapter 3, the Ropivacaine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ropivacaine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Ropivacaine market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Ropivacaine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Ropivacaine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Ropivacaine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Lumbar Epidural Administration
1.2.3 Thoracic Epidural Administration
1.2.4 Regional Block
1.3 Market Analysis by Application
1.3.1 Overview: Global Ropivacaine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Anesthesia
1.3.3 Systemic Neuropathic Pain
1.3.4 Postherpes Pain
1.3.5 Post-Operative Pain
1.3.6 Surgical Analgesia
1.3.7 Labor Analgesia
1.3.8 Other
1.4 Global Ropivacaine Market Size & Forecast
1.4.1 Global Ropivacaine Sales in Value (2016-2026))
1.4.2 Global Ropivacaine Sales in Volume (2016-2026)
1.4.3 Global Ropivacaine Price by Type (2016-2026) & (US$/Dose)
1.5 Global Ropivacaine Production Capacity Analysis
1.5.1 Global Ropivacaine Total Production Capacity (2016-2026)
1.5.2 Global Ropivacaine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Ropivacaine Market Drivers
1.6.2 Ropivacaine Market Restraints
1.6.3 Ropivacaine Trends Analysis
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Ropivacaine Product and Services
2.1.4 AstraZeneca Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Aspen Pharmacare
2.2.1 Aspen Pharmacare Details
2.2.2 Aspen Pharmacare Major Business
2.2.3 Aspen Pharmacare Ropivacaine Product and Services
2.2.4 Aspen Pharmacare Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Celgene
2.3.1 Celgene Details
2.3.2 Celgene Major Business
2.3.3 Celgene Ropivacaine Product and Services
2.3.4 Celgene Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Taiwan Liposome Company
2.4.1 Taiwan Liposome Company Details
2.4.2 Taiwan Liposome Company Major Business
2.4.3 Taiwan Liposome Company Ropivacaine Product and Services
2.4.4 Taiwan Liposome Company Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Nuvo Pharmaceuticals
2.5.1 Nuvo Pharmaceuticals Details
2.5.2 Nuvo Pharmaceuticals Major Business
2.5.3 Nuvo Pharmaceuticals Ropivacaine Product and Services
2.5.4 Nuvo Pharmaceuticals Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Heron Therapeutics
2.6.1 Heron Therapeutics Details
2.6.2 Heron Therapeutics Major Business
2.6.3 Heron Therapeutics Ropivacaine Product and Services
2.6.4 Heron Therapeutics Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Encore Therapeutics
2.7.1 Encore Therapeutics Details
2.7.2 Encore Therapeutics Major Business
2.7.3 Encore Therapeutics Ropivacaine Product and Services
2.7.4 Encore Therapeutics Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 PainReform Ltd
2.8.1 PainReform Ltd Details
2.8.2 PainReform Ltd Major Business
2.8.3 PainReform Ltd Ropivacaine Product and Services
2.8.4 PainReform Ltd Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Anhui Wellman Pharmaceutical
2.9.1 Anhui Wellman Pharmaceutical Details
2.9.2 Anhui Wellman Pharmaceutical Major Business
2.9.3 Anhui Wellman Pharmaceutical Ropivacaine Product and Services
2.9.4 Anhui Wellman Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Yichang Renfu Pharmaceutical
2.10.1 Yichang Renfu Pharmaceutical Details
2.10.2 Yichang Renfu Pharmaceutical Major Business
2.10.3 Yichang Renfu Pharmaceutical Ropivacaine Product and Services
2.10.4 Yichang Renfu Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Shandong New Era Pharmaceutical
2.11.1 Shandong New Era Pharmaceutical Details
2.11.2 Shandong New Era Pharmaceutical Major Business
2.11.3 Shandong New Era Pharmaceutical Ropivacaine Product and Services
2.11.4 Shandong New Era Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Shanxi Pude Pharmaceutical
2.12.1 Shanxi Pude Pharmaceutical Details
2.12.2 Shanxi Pude Pharmaceutical Major Business
2.12.3 Shanxi Pude Pharmaceutical Ropivacaine Product and Services
2.12.4 Shanxi Pude Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Guangdong Huarun Shunfeng Pharmaceutical
2.13.1 Guangdong Huarun Shunfeng Pharmaceutical Details
2.13.2 Guangdong Huarun Shunfeng Pharmaceutical Major Business
2.13.3 Guangdong Huarun Shunfeng Pharmaceutical Ropivacaine Product and Services
2.13.4 Guangdong Huarun Shunfeng Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Guangdong Jiabo Pharmaceutical
2.14.1 Guangdong Jiabo Pharmaceutical Details
2.14.2 Guangdong Jiabo Pharmaceutical Major Business
2.14.3 Guangdong Jiabo Pharmaceutical Ropivacaine Product and Services
2.14.4 Guangdong Jiabo Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Chengdu Tiantaishan Pharmaceutical
2.15.1 Chengdu Tiantaishan Pharmaceutical Details
2.15.2 Chengdu Tiantaishan Pharmaceutical Major Business
2.15.3 Chengdu Tiantaishan Pharmaceutical Ropivacaine Product and Services
2.15.4 Chengdu Tiantaishan Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Yangtze Pharmaceutical Group
2.16.1 Yangtze Pharmaceutical Group Details
2.16.2 Yangtze Pharmaceutical Group Major Business
2.16.3 Yangtze Pharmaceutical Group Ropivacaine Product and Services
2.16.4 Yangtze Pharmaceutical Group Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 Jiangsu Hengrui Pharmaceutical
2.17.1 Jiangsu Hengrui Pharmaceutical Details
2.17.2 Jiangsu Hengrui Pharmaceutical Major Business
2.17.3 Jiangsu Hengrui Pharmaceutical Ropivacaine Product and Services
2.17.4 Jiangsu Hengrui Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 Jiangsu Enhua Pharmaceutical
2.18.1 Jiangsu Enhua Pharmaceutical Details
2.18.2 Jiangsu Enhua Pharmaceutical Major Business
2.18.3 Jiangsu Enhua Pharmaceutical Ropivacaine Product and Services
2.18.4 Jiangsu Enhua Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.19 Hebei Yipin Pharmaceutical
2.19.1 Hebei Yipin Pharmaceutical Details
2.19.2 Hebei Yipin Pharmaceutical Major Business
2.19.3 Hebei Yipin Pharmaceutical Ropivacaine Product and Services
2.19.4 Hebei Yipin Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.20 Zhejiang Xianju Pharmaceutical
2.20.1 Zhejiang Xianju Pharmaceutical Details
2.20.2 Zhejiang Xianju Pharmaceutical Major Business
2.20.3 Zhejiang Xianju Pharmaceutical Ropivacaine Product and Services
2.20.4 Zhejiang Xianju Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.21 Hainan Sida Pharmaceutical
2.21.1 Hainan Sida Pharmaceutical Details
2.21.2 Hainan Sida Pharmaceutical Major Business
2.21.3 Hainan Sida Pharmaceutical Ropivacaine Product and Services
2.21.4 Hainan Sida Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.22 Xi'an Hanfeng Pharmaceutical
2.22.1 Xi'an Hanfeng Pharmaceutical Details
2.22.2 Xi'an Hanfeng Pharmaceutical Major Business
2.22.3 Xi'an Hanfeng Pharmaceutical Ropivacaine Product and Services
2.22.4 Xi'an Hanfeng Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.23 Chenxin Pharmaceutical
2.23.1 Chenxin Pharmaceutical Details
2.23.2 Chenxin Pharmaceutical Major Business
2.23.3 Chenxin Pharmaceutical Ropivacaine Product and Services
2.23.4 Chenxin Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.24 Shaanxi Bosen Biopharmaceutical
2.24.1 Shaanxi Bosen Biopharmaceutical Details
2.24.2 Shaanxi Bosen Biopharmaceutical Major Business
2.24.3 Shaanxi Bosen Biopharmaceutical Ropivacaine Product and Services
2.24.4 Shaanxi Bosen Biopharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.25 Qilu Pharmaceutical
2.25.1 Qilu Pharmaceutical Details
2.25.2 Qilu Pharmaceutical Major Business
2.25.3 Qilu Pharmaceutical Ropivacaine Product and Services
2.25.4 Qilu Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.26 Shenyang Sansheng Pharmaceutical
2.26.1 Shenyang Sansheng Pharmaceutical Details
2.26.2 Shenyang Sansheng Pharmaceutical Major Business
2.26.3 Shenyang Sansheng Pharmaceutical Ropivacaine Product and Services
2.26.4 Shenyang Sansheng Pharmaceutical Ropivacaine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Ropivacaine Sales by Manufacturer
3.1 Global Ropivacaine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Ropivacaine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Ropivacaine
3.4 Market Concentration Rate
3.4.1 Top 3 Ropivacaine Manufacturer Market Share
3.4.2 Top 6 Ropivacaine Manufacturer Market Share
3.5 Global Ropivacaine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Ropivacaine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Ropivacaine Market Size by Region
4.1.1 Global Ropivacaine Sales in Volume by Region (2016-2026)
4.1.2 Global Ropivacaine Revenue by Region (2016-2026)
4.2 North America Ropivacaine Revenue (2016-2026)
4.3 Europe Ropivacaine Revenue (2016-2026)
4.4 Asia-Pacific Ropivacaine Revenue (2016-2026)
4.5 South America Ropivacaine Revenue (2016-2026)
4.6 Middle East and Africa Ropivacaine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Ropivacaine Sales in Volume by Type (2016-2026)
5.2 Global Ropivacaine Revenue by Type (2016-2026)
5.3 Global Ropivacaine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Ropivacaine Sales in Volume by Application (2016-2026)
6.2 Global Ropivacaine Revenue by Application (2016-2026)
6.3 Global Ropivacaine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Ropivacaine Sales by Type (2016-2026)
7.2 North America Ropivacaine Sales by Application (2016-2026)
7.3 North America Ropivacaine Market Size by Country
7.3.1 North America Ropivacaine Sales in Volume by Country (2016-2026)
7.3.2 North America Ropivacaine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Ropivacaine Sales by Type (2016-2026)
8.2 Europe Ropivacaine Sales by Application (2016-2026)
8.3 Europe Ropivacaine Market Size by Country
8.3.1 Europe Ropivacaine Sales in Volume by Country (2016-2026)
8.3.2 Europe Ropivacaine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Ropivacaine Sales by Type (2016-2026)
9.2 Asia-Pacific Ropivacaine Sales by Application (2016-2026)
9.3 Asia-Pacific Ropivacaine Market Size by Region
9.3.1 Asia-Pacific Ropivacaine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Ropivacaine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Ropivacaine Sales by Type (2016-2026)
10.2 South America Ropivacaine Sales by Application (2016-2026)
10.3 South America Ropivacaine Market Size by Country
10.3.1 South America Ropivacaine Sales in Volume by Country (2016-2026)
10.3.2 South America Ropivacaine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Ropivacaine Sales by Type (2016-2026)
11.2 Middle East & Africa Ropivacaine Sales by Application (2016-2026)
11.3 Middle East & Africa Ropivacaine Market Size by Country
11.3.1 Middle East & Africa Ropivacaine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Ropivacaine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Ropivacaine Typical Distributors
12.3 Ropivacaine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Ropivacaine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Ropivacaine Revenue by Application, (USD Million), 2021-2026
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Ropivacaine Product and Services
Table 6. AstraZeneca Ropivacaine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Aspen Pharmacare Basic Information, Manufacturing Base and Competitors
Table 8. Aspen Pharmacare Major Business
Table 9. Aspen Pharmacare Ropivacaine Product and Services
Table 10. Aspen Pharmacare Ropivacaine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Celgene Basic Information, Manufacturing Base and Competitors
Table 12. Celgene Major Business
Table 13. Celgene Ropivacaine Product and Services
Table 14. Celgene Ropivacaine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Taiwan Liposome Company Basic Information, Manufacturing Base and Competitors
Table 16. Taiwan Liposome Company Major Business
Table 17. Taiwan Liposome Company Ropivacaine Product and Services
Table 18. Taiwan Liposome Company Ropivacaine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Nuvo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Nuvo Pharmaceuticals Major Business
Table 21. Nuvo Pharmaceuticals Ropivacaine Product and Services
Table 22. Nuvo Pharmaceuticals Ropivacaine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Heron Therapeutics Basic Information, Manufacturing Base and Competitors
Table 24. Heron Therapeutics Major Business
Table 25. Heron Therapeutics Ropivacaine Product and Services
Table 26. Heron Therapeutics Ropivacaine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Encore Therapeutics Basic Information, Manufacturing Base and Competitors
Table 28. Encore Therapeutics Major Business
Table 29. Encore Therapeutics Ropivacaine Product and Services
Table 30. Encore Therapeutics Ropivacaine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. PainReform Ltd Basic Information, Manufacturing Base and Competitors
Table 32. PainReform Ltd Major Business
Table 33. PainReform Ltd Ropivacaine Product and Services
Table 34. PainReform Ltd Ropivacaine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Anhui Wellman Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 36. Anhui Wellman Pharmaceutical Major Business
Table 37. Anhui Wellman Pharmaceutical Ropivacaine Product and Services
Table 38. Anhui Wellman Pharmaceutical Ropivacaine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Yichang Renfu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 40. Yichang Renfu Pharmaceutical Major Business
Table 41. Yichang Renfu Pharmaceutical Ropivacaine Product and Services
Table 42. Yichang Renfu Pharmaceutical Ropivacaine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Shandong New Era Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Shandong New Era Pharmaceutical Major Business
Table 45. Shandong New Era Pharmaceutical Ropivacaine Product and Services
Table 46. Shandong New Era Pharmaceutical Ropivacaine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Shanxi Pude Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 48. Shanxi Pude Pharmaceutical Major Business
Table 49. Shanxi Pude Pharmaceutical Ropivacaine Product and Services
Table 50. Shanxi Pude Pharmaceutical Ropivacaine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Guangdong Huarun Shunfeng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 52. Guangdong Huarun Shunfeng Pharmaceutical Major Business
Table 53. Guangdong Huarun Shunfeng Pharmaceutical Ropivacaine Product and Services
Table 54. Guangdong Huarun Shunfeng Pharmaceutical Ropivacaine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Guangdong Jiabo Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 56. Guangdong Jiabo Pharmaceutical Major Business
Table 57. Guangdong Jiabo Pharmaceutical Ropivacaine Product and Services
Table 58. Guangdong Jiabo Pharmaceutical Ropivacaine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Chengdu Tiantaishan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 60. Chengdu Tiantaishan Pharmaceutical Major Business
Table 61. Chengdu Tiantaishan Pharmaceutical Ropivacaine Product and Services
Table 62. Chengdu Tiantaishan Pharmaceutical Ropivacaine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Yangtze Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 64. Yangtze Pharmaceutical Group Major Business
Table 65. Yangtze Pharmaceutical Group Ropivacaine Product and Services
Table 66. Yangtze Pharmaceutical Group Ropivacaine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Jiangsu Hengrui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Jiangsu Hengrui Pharmaceutical Major Business
Table 69. Jiangsu Hengrui Pharmaceutical Ropivacaine Product and Services
Table 70. Jiangsu Hengrui Pharmaceutical Ropivacaine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Jiangsu Enhua Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 72. Jiangsu Enhua Pharmaceutical Major Business
Table 73. Jiangsu Enhua Pharmaceutical Ropivacaine Product and Services
Table 74. Jiangsu Enhua Pharmaceutical Ropivacaine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Hebei Yipin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 76. Hebei Yipin Pharmaceutical Major Business
Table 77. Hebei Yipin Pharmaceutical Ropivacaine Product and Services
Table 78. Hebei Yipin Pharmaceutical Ropivacaine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Zhejiang Xianju Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 80. Zhejiang Xianju Pharmaceutical Major Business
Table 81. Zhejiang Xianju Pharmaceutical Ropivacaine Product and Services
Table 82. Zhejiang Xianju Pharmaceutical Ropivacaine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Hainan Sida Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 84. Hainan Sida Pharmaceutical Major Business
Table 85. Hainan Sida Pharmaceutical Ropivacaine Product and Services
Table 86. Hainan Sida Pharmaceutical Ropivacaine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. Xi'an Hanfeng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 88. Xi'an Hanfeng Pharmaceutical Major Business
Table 89. Xi'an Hanfeng Pharmaceutical Ropivacaine Product and Services
Table 90. Xi'an Hanfeng Pharmaceutical Ropivacaine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 91. Chenxin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 92. Chenxin Pharmaceutical Major Business
Table 93. Chenxin Pharmaceutical Ropivacaine Product and Services
Table 94. Chenxin Pharmaceutical Ropivacaine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 95. Shaanxi Bosen Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 96. Shaanxi Bosen Biopharmaceutical Major Business
Table 97. Shaanxi Bosen Biopharmaceutical Ropivacaine Product and Services
Table 98. Shaanxi Bosen Biopharmaceutical Ropivacaine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 99. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 100. Qilu Pharmaceutical Major Business
Table 101. Qilu Pharmaceutical Ropivacaine Product and Services
Table 102. Qilu Pharmaceutical Ropivacaine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 103. Shenyang Sansheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 104. Shenyang Sansheng Pharmaceutical Major Business
Table 105. Shenyang Sansheng Pharmaceutical Ropivacaine Product and Services
Table 106. Shenyang Sansheng Pharmaceutical Ropivacaine Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 107. Global Ropivacaine Sales by Manufacturer (2019-2021e) & (K Doses)
Table 108. Global Ropivacaine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 109. Market Position of Manufacturers in Ropivacaine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 110. Global Ropivacaine Production Capacity by Company, (K Doses): 2020 VS 2021
Table 111. Head Office and Ropivacaine Production Site of Key Manufacturer
Table 112. Ropivacaine New Entrant and Capacity Expansion Plans
Table 113. Ropivacaine Mergers & Acquisitions in the Past Five Years
Table 114. Global Ropivacaine Sales by Region (2016-2021e) & (K Doses)
Table 115. Global Ropivacaine Sales by Region (2021-2026) & (K Doses)
Table 116. Global Ropivacaine Revenue by Region (2016-2021e) & (USD Million)
Table 117. Global Ropivacaine Revenue by Region (2021-2026) & (USD Million)
Table 118. Global Ropivacaine Sales by Type (2016-2021e) & (K Doses)
Table 119. Global Ropivacaine Sales by Type (2021-2026) & (K Doses)
Table 120. Global Ropivacaine Revenue by Type (2016-2021e) & (USD Million)
Table 121. Global Ropivacaine Revenue by Type (2021-2026) & (USD Million)
Table 122. Global Ropivacaine Price by Type (2016-2021e) & (US$/Dose)
Table 123. Global Ropivacaine Price by Type (2021-2026) & (US$/Dose)
Table 124. Global Ropivacaine Sales by Application (2016-2021e) & (K Doses)
Table 125. Global Ropivacaine Sales by Application (2021-2026) & (K Doses)
Table 126. Global Ropivacaine Revenue by Application (2016-2021e) & (USD Million)
Table 127. Global Ropivacaine Revenue by Application (2021-2026) & (USD Million)
Table 128. Global Ropivacaine Price by Application (2016-2021e) & (US$/Dose)
Table 129. Global Ropivacaine Price by Application (2021-2026) & (US$/Dose)
Table 130. North America Ropivacaine Sales by Country (2016-2021e) & (K Doses)
Table 131. North America Ropivacaine Sales by Country (2021-2026) & (K Doses)
Table 132. North America Ropivacaine Revenue by Country (2016-2021e) & (USD Million)
Table 133. North America Ropivacaine Revenue by Country (2021-2026) & (USD Million)
Table 134. North America Ropivacaine Sales by Type (2016-2021e) & (K Doses)
Table 135. North America Ropivacaine Sales by Type (2021-2026) & (K Doses)
Table 136. North America Ropivacaine Sales by Application (2016-2021e) & (K Doses)
Table 137. North America Ropivacaine Sales by Application (2021-2026) & (K Doses)
Table 138. Europe Ropivacaine Sales by Country (2016-2021e) & (K Doses)
Table 139. Europe Ropivacaine Sales by Country (2021-2026) & (K Doses)
Table 140. Europe Ropivacaine Revenue by Country (2016-2021e) & (USD Million)
Table 141. Europe Ropivacaine Revenue by Country (2021-2026) & (USD Million)
Table 142. Europe Ropivacaine Sales by Type (2016-2021e) & (K Doses)
Table 143. Europe Ropivacaine Sales by Type (2021-2026) & (K Doses)
Table 144. Europe Ropivacaine Sales by Application (2016-2021e) & (K Doses)
Table 145. Europe Ropivacaine Sales by Application (2021-2026) & (K Doses)
Table 146. Asia-Pacific Ropivacaine Sales by Region (2016-2021e) & (K Doses)
Table 147. Asia-Pacific Ropivacaine Sales by Region (2021-2026) & (K Doses)
Table 148. Asia-Pacific Ropivacaine Revenue by Region (2016-2021e) & (USD Million)
Table 149. Asia-Pacific Ropivacaine Revenue by Region (2021-2026) & (USD Million)
Table 150. Asia-Pacific Ropivacaine Sales by Type (2016-2021e) & (K Doses)
Table 151. Asia-Pacific Ropivacaine Sales by Type (2021-2026) & (K Doses)
Table 152. Asia-Pacific Ropivacaine Sales by Application (2016-2021e) & (K Doses)
Table 153. Asia-Pacific Ropivacaine Sales by Application (2021-2026) & (K Doses)
Table 154. South America Ropivacaine Sales by Country (2016-2021e) & (K Doses)
Table 155. South America Ropivacaine Sales by Country (2021-2026) & (K Doses)
Table 156. South America Ropivacaine Revenue by Country (2016-2021e) & (USD Million)
Table 157. South America Ropivacaine Revenue by Country (2021-2026) & (USD Million)
Table 158. South America Ropivacaine Sales by Type (2016-2021e) & (K Doses)
Table 159. South America Ropivacaine Sales by Type (2021-2026) & (K Doses)
Table 160. South America Ropivacaine Sales by Application (2016-2021e) & (K Doses)
Table 161. South America Ropivacaine Sales by Application (2021-2026) & (K Doses)
Table 162. Middle East & Africa Ropivacaine Sales by Country (2016-2021e) & (K Doses)
Table 163. Middle East & Africa Ropivacaine Sales by Country (2021-2026) & (K Doses)
Table 164. Middle East & Africa Ropivacaine Revenue by Country (2016-2021e) & (USD Million)
Table 165. Middle East & Africa Ropivacaine Revenue by Country (2021-2026) & (USD Million)
Table 166. Middle East & Africa Ropivacaine Sales by Type (2016-2021e) & (K Doses)
Table 167. Middle East & Africa Ropivacaine Sales by Type (2021-2026) & (K Doses)
Table 168. Middle East & Africa Ropivacaine Sales by Application (2016-2021e) & (K Doses)
Table 169. Middle East & Africa Ropivacaine Sales by Application (2021-2026) & (K Doses)
Table 170. Direct Channel Pros & Cons
Table 171. Indirect Channel Pros & Cons
Table 172. Ropivacaine Typical Distributors
Table 173. Ropivacaine Typical Customers
List of Figures
Figure 1. Ropivacaine Picture
Figure 2. Global Ropivacaine Sales Market Share by Type in 2020
Figure 3. Lumbar Epidural Administration
Figure 4. Thoracic Epidural Administration
Figure 5. Regional Block
Figure 6. Global Ropivacaine Sales Market Share by Application in 2020
Figure 7. Anesthesia
Figure 8. Systemic Neuropathic Pain
Figure 9. Postherpes Pain
Figure 10. Post-Operative Pain
Figure 11. Surgical Analgesia
Figure 12. Labor Analgesia
Figure 13. Other
Figure 14. Global Ropivacaine Market Size, (USD Million) & (K Doses): 2020 VS 2021 VS 2026
Figure 15. Global Ropivacaine Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. Global Ropivacaine Sales (2016-2026) & (K Doses)
Figure 17. Global Ropivacaine Price by Type (2016-2026) & (US$/Dose)
Figure 18. Global Ropivacaine Production Capacity (2016-2026) & (K Doses)
Figure 19. Global Ropivacaine Production Capacity by Geographic Region: 2020 VS 2021
Figure 20. Ropivacaine Market Drivers
Figure 21. Ropivacaine Market Restraints
Figure 22. Ropivacaine Market Trends
Figure 23. Global Ropivacaine Sales Market Share by Manufacturer in 2020
Figure 24. Global Ropivacaine Revenue Market Share by Manufacturer in 2020
Figure 25. Ropivacaine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. Top 3 Ropivacaine Manufacturer (Revenue) Market Share in 2020
Figure 27. Top 6 Ropivacaine Manufacturer (Revenue) Market Share in 2020
Figure 28. Global Ropivacaine Sales Market Share by Region (2016-2026)
Figure 29. Global Ropivacaine Revenue Market Share by Region (2016-2026)
Figure 30. North America Ropivacaine Revenue (2016-2026) & (USD Million)
Figure 31. Europe Ropivacaine Revenue (2016-2026) & (USD Million)
Figure 32. Asia-Pacific Ropivacaine Revenue (2016-2026) & (USD Million)
Figure 33. South America Ropivacaine Revenue (2016-2026) & (USD Million)
Figure 34. Middle East & Africa Ropivacaine Revenue (2016-2026) & (USD Million)
Figure 35. Global Ropivacaine Sales Market Share by Type (2016-2026)
Figure 36. Global Ropivacaine Revenue Market Share by Type (2016-2026)
Figure 37. Global Ropivacaine Price by Type (2016-2026) & (US$/Dose)
Figure 38. Global Ropivacaine Sales Market Share by Application (2016-2026)
Figure 39. Global Ropivacaine Revenue Market Share by Application (2016-2026)
Figure 40. Global Ropivacaine Price by Application (2016-2026) & (US$/Dose)
Figure 41. North America Ropivacaine Sales Market Share by Type (2016-2026)
Figure 42. North America Ropivacaine Sales Market Share by Application (2016-2026)
Figure 43. North America Ropivacaine Sales Market Share by Country (2016-2026)
Figure 44. North America Ropivacaine Revenue Market Share by Country (2016-2026)
Figure 45. United States Ropivacaine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Ropivacaine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Ropivacaine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Ropivacaine Sales Market Share by Type (2016-2026)
Figure 49. Europe Ropivacaine Sales Market Share by Application (2016-2026)
Figure 50. Europe Ropivacaine Sales Market Share by Country (2016-2026)
Figure 51. Europe Ropivacaine Revenue Market Share by Country (2016-2026)
Figure 52. Germany Ropivacaine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Ropivacaine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Ropivacaine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Ropivacaine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Ropivacaine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Ropivacaine Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Ropivacaine Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Ropivacaine Sales Market Share by Region (2016-2026)
Figure 60. Asia-Pacific Ropivacaine Revenue Market Share by Region (2016-2026)
Figure 61. China Ropivacaine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Ropivacaine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Korea Ropivacaine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Ropivacaine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Ropivacaine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Ropivacaine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Ropivacaine Sales Market Share by Type (2016-2026)
Figure 68. South America Ropivacaine Sales Market Share by Application (2016-2026)
Figure 69. South America Ropivacaine Sales Market Share by Country (2016-2026)
Figure 70. South America Ropivacaine Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Ropivacaine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Ropivacaine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East & Africa Ropivacaine Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Ropivacaine Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Ropivacaine Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Ropivacaine Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Ropivacaine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Egypt Ropivacaine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Ropivacaine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. South Africa Ropivacaine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source